D441 Medical Dosage Calculations and Pharmacology - Set 1 - Part 3

Correct Answer: Schedule two, due to high potential for physical and psychological addiction

Option a is correct because oxycodone is a Schedule II controlled substance under the Controlled Substances Act, characterized by high potential for physical and psychological addiction and requiring a written prescription with absolutely no refills permitted. Option b is incorrect because Schedule III substances are combination products containing limited narcotic amounts like acetaminophen with codeine; pure oxycodone's high addiction potential places it in the more restrictive Schedule II category. Option c is incorrect because Schedule IV substances like benzodiazepines have significantly lower abuse potential than oxycodone; placing oxycodone in this category would dangerously underestimate its well-documented addiction and misuse potential. Option d is incorrect because Schedule V substances represent the lowest abuse potential category and include products like cough suppressants with small amounts of codeine; oxycodone's properties are nowhere near this classification

Correct Answer: Pharmacokinetics describes how the body processes a drug; pharmacodynamics describes the drug's effect on the body

Option c is correct because pharmacokinetics covers absorption, distribution, metabolism, and excretion of drugs through the body; pharmacodynamics covers the biochemical and physiological effects the drug produces once it reaches its target receptor sites. Option a is incorrect because the definitions are reversed; pharmacokinetics studies drug movement through the body during absorption, distribution, metabolism, and excretion, while pharmacodynamics focuses on the drug's effects on body systems. Option b is incorrect because pharmacokinetics is not limited to toxicity study and pharmacodynamics is not restricted to drug interactions; these concepts encompass drug movement and drug effects as broad distinct disciplines. Option d is incorrect because pharmacokinetics and pharmacodynamics represent fundamentally different concepts describing distinct aspects of drug behavior; they are not synonymous terms and study entirely separate dimensions of drug action.

Correct Answer: Topical transdermal, because the medication is applied to and absorbed through the skin surface

Option d is correct because topical transdermal administration involves applying medication directly to the skin for systemic absorption; patches deliver consistent drug levels through the skin, bypassing the gastrointestinal tract and providing sustained controlled release. Option a is incorrect because enteral administration involves the gastrointestinal tract through oral, sublingual, or nasogastric routes; applying medication to the outer skin surface does not engage the gastrointestinal system at all. Option b is incorrect because parenteral administration refers to injection routes such as intravenous, intramuscular, or subcutaneous; applying a patch to the skin surface is distinctly different from any injectable parenteral delivery method. Option c is incorrect because sublingual administration involves placing medication under the tongue where it absorbs through the oral mucosa; this is entirely different from applying medication to the outer skin surface.

Correct Answer: Antagonism, where naloxone blocks opioid receptors reversing analgesia and triggering withdrawal

Option b is correct because naloxone is a competitive opioid antagonist that blocks opioid receptors without activating them; immediate reversal of analgesia combined with agitation, tachycardia, and pain reflects abrupt precipitated withdrawal from full antagonist activity. Option a is incorrect because synergism describes two drugs enhancing each other's combined effects; naloxone and morphine have directly opposing effects since naloxone actively blocks the receptors that morphine activates for pain relief. Option c is incorrect because naloxone is a pure antagonist with zero receptor-activating activity; it fully blocks all opioid receptors without producing any analgesic or sedative effect of its own at the receptor. Option d is incorrect because tolerance refers to decreased drug response over time with repeated exposure; the immediate agitation and complete pain reversal seen here is caused by naloxone's receptor-blocking mechanism specifically.

Correct Answer: Phase two, which evaluates drug efficacy in patients with the targeted condition

Option a is correct because Phase two clinical trials involve hundreds of patients with the targeted disease to evaluate whether the drug produces the desired therapeutic effect called efficacy, under more disease-specific real-world conditions. Option b is incorrect because Phase one involves a small number of healthy volunteers to assess initial drug safety and harmful effects; it does not test efficacy in patients who actually have the target disease. Option c is incorrect because Phase three expands to hundreds or thousands of participants across multiple facilities to confirm safety, effectiveness, and optimal dosing; this larger scale exceeds the Phase two scenario described. Option d is incorrect because Phase four occurs after FDA approval and monitors long-term real-world drug effects in the general population; the drug described is still in pre-approval human efficacy testing.

Correct Answer: Dyskinesia from excessive dopamine levels, indicating a possible need for dose adjustment

Option c is correct because dyskinesia is a sign of levodopa toxicity caused by too much dopamine activity; involuntary writhing or uncontrolled movements develop when carbidopa and levodopa therapy overshoots the intended dopamine correction in the brain. Option a is incorrect because bradykinesia is characterized by slowness of movement and rigidity caused by too little dopamine; uncontrolled writhing movements point toward excessive dopamine from high levodopa doses instead. Option b is incorrect because tardive dyskinesia involves repetitive stereotyped facial movements from long-term dopamine blockers; the writhing limb movements here are specifically associated with levodopa excess in Parkinson's treatment. Option d is incorrect because uncontrolled involuntary writhing movements are not a therapeutic response to levodopa; they represent a dose-related complication of excessive dopamine activity requiring clinical evaluation and likely dose adjustment.

Correct Answer: Rhabdomyolysis, a dangerous breakdown of muscle tissue that must be reported immediately

Option b is correct because cola-colored urine combined with severe diffuse muscle pain is the classic presentation of rhabdomyolysis, a serious statin adverse effect involving skeletal muscle breakdown that releases myoglobin and damages the kidneys. Option a is incorrect because hepatotoxicity from statins typically presents with elevated liver enzymes, jaundice, and abdominal pain; cola-colored urine with severe muscle pain specifically and classically points to rhabdomyolysis. Option c is incorrect because severe diffuse muscle pain with cola-colored urine is never a normal statin adjustment response; these are classic warning signs of rhabdomyolysis requiring immediate provider notification and medication discontinuation. Option d is incorrect because dehydration causes dark concentrated yellow urine, not cola-colored urine; the distinctive cola or tea color combined with muscle pain specifically indicates myoglobin spillage from active muscle breakdown.

Correct Answer: Sit upright or walk for at least thirty minutes after taking to prevent esophageal damage

Option d is correct because bisphosphonates like alendronate can cause severe esophagitis and esophageal ulceration if the patient reclines after taking them; remaining upright for at least thirty minutes allows the tablet to fully clear the esophagus safely. Option a is incorrect because alendronate must be taken with plain water on an empty stomach; calcium-rich foods like milk bind bisphosphonates in the gastrointestinal tract and significantly reduce the medication's absorption and effectiveness. Option b is incorrect because alendronate tablets must never be crushed or altered; the drug must be swallowed whole with a full glass of water to prevent direct esophageal mucosal contact and chemical irritation. Option c is incorrect because lying flat after alendronate increases the risk of esophageal reflux and chemical ulceration; the patient must maintain an upright position to prevent the tablet from contacting sensitive esophageal tissue.

Correct Answer: Creatinine and BUN for nephrotoxicity, and AST and ALT for hepatotoxicity

Option a is correct because cyclosporine is an immunosuppressant with dual organ toxicity risks; creatinine and BUN monitor for kidney damage while AST and ALT monitor for hepatic injury, both being primary safety concerns during ongoing therapy. Option b is incorrect because sodium and chloride monitoring is not the priority for cyclosporine toxicity; kidney and liver function tests are the primary indicators for the two most serious complications of this drug. Option c is incorrect because while cyclosporine inhibits T cell activation, its most serious and monitored toxicities are nephrotoxicity and hepatotoxicity rather than direct white blood cell production suppression requiring CBC-only monitoring. Option d is incorrect because blood glucose monitoring is more relevant to corticosteroid therapy than to cyclosporine specifically; cyclosporine's primary monitored organ toxicities are kidney and liver damage requiring targeted lab surveillance.

Correct Answer: Donepezil is administered at night because its side effects like dizziness are better tolerated during sleep

Option c is correct because donepezil is recommended at bedtime because its most common side effects including dizziness, nausea, and headache are better tolerated while the patient sleeps, reducing fall risk and discomfort during waking hours. Option a is incorrect because bedtime administration of donepezil is not related to stomach acid timing or gastrointestinal absorption pharmacokinetics; the reason is purely about managing adverse effects during non-waking hours. Option b is incorrect because donepezil does not have a clinically significant food or breakfast vitamin interaction requiring bedtime dosing; the timing is specifically selected to minimize the patient's experience of adverse effects. Option d is incorrect because bedtime administration of donepezil is the standard recommended timing, not a pharmacy error; this approach is an intentional clinical practice specifically designed to manage side effects during sleep.